Christopher Moxham
Director Ejecutivo en Rarebase, PBC .
Cargos activos de Christopher Moxham
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Rarebase, PBC
 Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation. | Director Ejecutivo | 04/10/2023 | - |
| Presidente | 13/07/2023 | - | |
| Director Técnico/Científico/I+D | - | 04/10/2023 |
Historial de carrera de Christopher Moxham
Antiguos cargos conocidos de Christopher Moxham.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| FULCRUM THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 05/02/2021 | - |
| Corporate Officer/Principal | 01/01/2019 | 05/02/2021 |
Formación de Christopher Moxham.
| Stony Brook University | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Rarebase, PBC
Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation. | Technology Services |
- Bolsa de valores
- Insiders
- Christopher Moxham
- Experiencia
